Want to join the conversation?
Biopharmaceutical company $AMGN said the randomized, double-blind , placebo-controlled Phase 3 Aranesp ARCADE trial met its primary endpoint of reducing incidence of RBC transfusions in anemic patients with low and intermediate-1 risk myelodysplastic syndrome (MDS) at the end of the 25-week study period.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.